Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment
Conditions: Alcohol Use Disorder; Cannabis Use Disorder Intervention: Behavioral: CBT Sponsors: Centre for Addiction and Mental Health; Canadian Institutes of Health Research (CIHR); Innovation Fund of the Alternative Funding Plan for the Academic Health Sciences Centres of Ontario Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2023 Category: Research Source Type: clinical trials
Venetoclax in Combination With 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy
Condition: Acute Myeloid Leukemia (AML) Intervention: Drug: VEN+AZA-5 Sponsors: University of Leipzig; AbbVie Deutschland GmbH & Co KG (funding); Hämatologisches Diagnostiklabor, University hospital Leipzig (central lab); ZKS Leipzig, University of Leipzig: project/data management, pharmacovigilance, biometry, monitoring Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2023 Category: Research Source Type: clinical trials
